Supernus, Inc. (SUPN) Insider Trading Activity

NASDAQ$27.8601-0.29 (-1.03%)
Market Cap
$1.64B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
789 of 849
Rank in Industry
43 of 48

SUPN Insider Trading Activity

SUPN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$10,264,930
13
100

Related Transactions

Sensenig Bethanydirector
0
$0
1
$228,265
$-228,265
Hudson Frederick M.director
0
$0
1
$271,725
$-271,725
Horich William ToddSVP, Commercial Operations
0
$0
2
$483,797
$-483,797
GEMAYEL GEORGESdirector
0
$0
2
$1M
$-1M
Mottola FrankSVP, Chief Tech. Ops. Officer
0
$0
2
$1.1M
$-1.1M
Khattar Jack A.President, CEO
0
$0
1
$1.76M
$-1.76M
Bhatt Padmanabh P.Sr. VP of IP, CSO
0
$0
4
$5.42M
$-5.42M

About Supernus, Inc.

Supernus, Inc. is a diversified biopharmaceutical company focused on developing and commercializing treatments for central nervous system (CNS) diseases. Its portfolio of 11 marketed products spans opioid use disorder, psychiatry, and neurology, and includes SUBLOCADE, a long-acting injectable buprenorphine for opioid use disorder, along with sublingual OUD treatments; Qelbree, a non-stimulant treatment for attention-deficit hyperactivity disorder (ADHD); GOCOVRI for dyskinesia in Parkinson’s disease patients receiving levodopa-based therapy; …

Insider Activity of Supernus, Inc.

Over the last 12 months, insiders at Supernus, Inc. have bought $0 and sold $10.26M worth of Supernus, Inc. stock.

On average, over the past 5 years, insiders at Supernus, Inc. have bought $0 and sold $11.98M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 14,400 shares for transaction amount of $379,964 was made by Khattar Jack A. (President, CEO) on 2019‑08‑23.

List of Insider Buy and Sell Transactions, Supernus, Inc.

2026-03-18SaleBhatt Padmanabh P.Sr. VP of IP, CSO
7,250
0.0127%
$49.60
$359,621
-5.34%
2026-03-17SaleBhatt Padmanabh P.Sr. VP of IP, CSO
50,000
0.0859%
$50.30
$2.51M
-8.09%
2026-03-16SaleBhatt Padmanabh P.Sr. VP of IP, CSO
50,000
0.087%
$50.28
$2.51M
-6.87%
2026-03-13SaleKhattar Jack A.President, CEO
35,000
0.0613%
$50.38
$1.76M
-6.27%
2026-03-12SaleHudson Frederick M.director
5,369
0.0094%
$50.61
$271,725
-7.25%
2026-03-10SaleHorich William ToddSVP, Commercial Operations
4,439
0.0078%
$55.00
$244,145
-12.73%
2026-03-09SaleMottola FrankSVP, Chief Tech. Ops. Officer
1,623
0.0028%
$53.65
$87,074
-13.52%
2026-03-09SaleHorich William ToddSVP, Commercial Operations
4,438
0.0077%
$54.00
$239,652
-13.52%
2026-03-06SaleGEMAYEL GEORGESdirector
8,787
0.015%
$53.00
$465,711
-13.03%
2026-03-05SaleGEMAYEL GEORGESdirector
10,000
0.0172%
$53.71
$537,100
-13.64%
2026-02-19SaleSensenig Bethanydirector
4,475
0.0079%
$51.01
$228,265
-8.26%
2025-12-19SaleMottola FrankSVP, Chief Tech. Ops. Officer
20,000
0.035%
$50.41
$1.01M
-6.56%
2025-12-18SaleBhatt Padmanabh P.Sr. VP of IP, CSO
710
0.0011%
$44.44
$31,552
-2.27%
2025-10-09SaleKhattar Jack A.President, CEO
59,900
0.1091%
$50.57
$3.03M
-2.50%
2025-10-09SaleNEWHALL CHARLES W IIIdirector
25,000
0.0457%
$50.77
$1.27M
-2.50%
2025-10-02SaleKhattar Jack A.President, CEO
1,904
0.0034%
$48.06
$91,506
+0.77%
2025-10-01SaleKhattar Jack A.President, CEO
40,173
0.0721%
$48.07
$1.93M
+0.60%
2025-09-30SaleKhattar Jack A.President, CEO
8,588
0.0155%
$48.25
$414,371
+1.13%
2025-09-29SaleKhattar Jack A.President, CEO
10,235
0.0184%
$48.02
$491,485
+1.53%
2025-09-23SaleKhattar Jack A.President, CEO
29,513
0.0531%
$47.23
$1.39M
+3.20%
Total: 181
*Gray background shows transactions not older than one year

Insider Historical Profitability

21.96%
Khattar Jack A.President, CEO
958100
1.6452%
$26.97M335
+14.22%
Hudson Frederick M.director
60413
0.1037%
$1.7M15
+29.48%
NEW ENTERPRISE ASSOCIATES 11 LP10 percent owner
10641250
18.2727%
$299.55M10
+29.48%
Abingworth Management LTD10 percent owner
3600000
6.1818%
$101.34M10
+29.48%
SHEFFERY MICHAEL Bdirector
2402600
4.1256%
$67.63M10
+29.48%
ORBIMED ADVISORS LLC10 percent owner
817000
1.4029%
$23M14
+29.48%
NEWHALL CHARLES W IIIdirector
104644
0.1797%
$2.95M16
+29.48%
Martin Tami TillotsonSr. V.P., Regulatory Affairs
85664
0.1471%
$2.41M17
+29.48%
PATRICK GREGORY SSr. VP Chief Financial Officer
44463
0.0764%
$1.25M214
+14.05%
BIGHAM MICHAELdirector
25000
0.0429%
$703,750.0020
+20.85%
Nuerge William A.director
23750
0.0408%
$668,562.5010
+29.48%
SIEBERT JOHN Mdirector
15188
0.0261%
$427,542.2030
+13.12%
BARRETT M JAMESdirector
0
0%
$0110
+29.48%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$1,279,728,023
131
10.76%
$3.05B
$25,613,591
65
-3.30%
$12.27B
$14,599,168
59
12.79%
$1.66B
$102,709,455
46
30.55%
$1.45B
$73,762,556
45
-9.99%
$2.17B

SUPN Institutional Investors: Active Positions

Increased Positions182+51.7%9M+15.89%
Decreased Positions153-43.47%11M-18.65%
New Positions64New4MNew
Sold Out Positions41Sold Out5MSold Out
Total Postitions381+8.24%57M-2.76%

SUPN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$430,310.0015.26%8.7M-5M-37.48%2025-09-30
Vanguard Group Inc$299,034.0010.61%6.04M-3M-36.18%2025-09-30
Dimensional Fund Advisors Lp$148,506.005.27%3M-893,432-22.94%2025-09-30
Armistice Capital, Llc$140,297.004.97%2.84M-2M-41.06%2025-09-30
Macquarie Group Ltd$125,235.004.44%2.53M-230,587-8.35%2025-09-30
State Street Corp$108,219.003.84%2.19M-1M-35.17%2025-09-30
Point72 Asset Management, L.P.$87,141.003.09%1.76M+1M+246.89%2025-09-30
Renaissance Technologies Llc$86,109.003.05%1.74M-1M-37.13%2025-09-30
Citadel Advisors Llc$70,095.002.49%1.42M+1M+300.86%2025-09-30
Geode Capital Management, Llc$69,754.002.47%1.41M-1M-48.84%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.